Evidence map›Paper›PMID 37284165›Full record

ArticleFree neuropathology2022

Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients.

Nuria Vidal-Robau, Gabriela Caballero, Ivan Archilla, Andrea Ladino, Sara Fernández, Valentín Ortiz-Maldonado, Montserrat Rovira, Marta Gómez-Hernando, Julio Delgado, María Suárez-Lledó and 14 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Free neuropathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 1 institution in 1 country.

Nuria Vidal-Robau *Pathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Gabriela Caballero *Pathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Ivan ArchillaPathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Andrea LadinoMedical Intensive Care Unit, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Sara FernándezMedical Intensive Care Unit, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Valentín Ortiz-MaldonadoHaematology Department, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Montserrat RoviraHaematology Department, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Marta Gómez-HernandoHaematology Department, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Julio DelgadoHaematology Department, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
María Suárez-LledóHaematology Department, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Carlos Fernández de LarreaHaematology Department, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Olga BalaguéPathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Gerard FrigolaPathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Abel MuñozPathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Estrella OrtizPathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Teresa RibaltaPathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Miguel J MartinezMicrobiology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Maria Angeles-MarcosMicrobiology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Marta Español-RegoImmunology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Azucena GonzálezImmunology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Daniel Benitez-RibasImmunology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Eugenia Martinez-HernandezNeurology Department, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Pedro CastroMedical Intensive Care Unit, Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Iban AldecoaPathology Department, Biomedical Diagnostic Centre (CDB), Hospital Clinic of Barcelona - University of Barcelona, Barcelona, Spain.
Hospital Clínic de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chimeric antigen receptor (CAR) T-cellCytokine release syndrome (CRS)Hematologic malignanciesImmunohistochemical stainsNeuropathologyNeurotoxicity

Identifiers

PMID37284165
PMCPMC10210002
OpenAlexW4379599335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.